Specifications
Target
Product Background
Pathway
Adaptive Immune System; Allograft Rejection; Allograft rejection; Autoimmune thyroid disease; CD28 co-stimulation; CD28 dependent PI3K/Akt signaling; CD28 dependent Vav1 pathway; CTLA4 inhibitory signaling; Cell adhesion molecules (CAMs); Constitutive PI3K/AKT Signaling in Cancer; Costimulation by the CD28 family;
Citations
Have you cited ABPR-0181 in a publication?
Let us know and earn a reward for your research.
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Wang, Y; Mealy, N; et al. Galiximab. Primatized anti-CD80 monoclonal antibody, treatment of non-Hodgkin's lymphoma. DRUGS OF THE FUTURE 32:854-858(2007).
Wang, WY; Yan, H; et al. Impairment of Monocyte-derived Dendritic Cells in Idiopathic Pulmonary Arterial Hypertension. JOURNAL OF CLINICAL IMMUNOLOGY 29:705-713(2009).
COA
Certificate of Analysis
